Elsevier

Neuropharmacology

Volume 32, Issue 11, November 1993, Pages 1279-1283, 1285-1288
Neuropharmacology

Nordihydroguaiaretic acid attenuates NMDA neurotoxicity—Action beyond the receptor

https://doi.org/10.1016/0028-3908(93)90022-UGet rights and content

Abstract

There is widespread interest in the neurotoxicity of the endogenous excitatory amino acid neurotransmitter glutamate. Excessive glutamate release or accumulation leads to neuronal injury or death in a variety of experimental models of ischemia, anoxia and hypoglycemia. This injury appears to be caused by overactivation of the N-methyl-d-aspartate (NMDA) subclass of glutamate receptors since a variety of competitive and uncompetitive NMDA antagonists can attenuate this process, sometimes in a dramatic fashion. Given the clinical context in which this form of neuronal injury occurs, it would be desirable if we could identify agents that blocked NMDA toxicity, after initial receptor binding and ion channel fluxes had transpired. Because NMDA receptor activation initiates the arachidonic acid cascade, we have recently looked at whether the phospholipase A2 and lipoxygenase inhibitor nordihydroguaiaretic acid (NDGA) can reduce NMDA neurotoxicity in vitro. In the concentration range 1–30 μM, NDGA diminished the death of cultured rodent hippocampal neurons produced by 100 μM NMDA. When 30 μM NDGA was present both before and after NMDA exposure, death declined by over 50%. NDGA did not block NMDA-induced inward currents in voltage-clamped neurons, so the drug is not a direct NMDA receptor antagonist. It also had no effect on the elevation in intracellular calcium produced by NMDA exposure.

It is likely that NDGA acts at a site(s) distal to the NMDA receptor and the neuronal membrane to limit NMDA toxicity. We are hopeful that strategies for limiting excitotoxicity, which halt destructive intracellular events, can be developed for use in human neurological diseases linked to excessive stimulation of glutamate receptors.

References (41)

  • D.W. Choi

    Ionic dependence of glutamate neurotoxicity in cortical cell culture

    J. Neurosci.

    (1987)
  • D.W. Choi

    Cerebral hypoxia: some new approaches and unanswered questions

    J. Neurosci.

    (1990)
  • D.W. Choi et al.

    The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death

    A. Rev. Neurosci.

    (1990)
  • D.W. Choi et al.

    Glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists

    J. Neurosci.

    (1988)
  • G.L. Collingridge et al.

    Excitatory amino acid receptors in the vertebrate central nervous system

    Pharmac. Rev.

    (1989)
  • V.L. Dawson et al.

    Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures

    P.N.A.S.

    (1991)
  • J.M. Dubinsky et al.

    Intracellular calcium concentrations during “chemical hypoxia” and excitotoxic neuronal injury

    J. Neurosci.

    (1991)
  • A. Dumuis et al.

    NMDA receptors activate the arachidonic acid cascade system in striatal neurons

    Nature

    (1988)
  • U. Forstermann et al.

    Mechanism of action of lipoxygenase and cytochrome P-450-monooxygenase inhibitors in blocking endothelium-dependent vasodilation

    Br. J. Pharmac.

    (1988)
  • J.S. Hahn et al.

    Central mammalian neurons normally resistant to glutamate toxicity are made sensitive by elevated extracellular Ca2+: toxicity is blocked by the N-methyl-d-aspartate antagonist MK-801

  • Cited by (57)

    • Ring substitution influences oxidative cyclisation and reactive metabolite formation of nordihydroguaiaretic acid analogues

      2015, Bioorganic and Medicinal Chemistry
      Citation Excerpt :

      NDGA is generally accepted as responsible for both beneficial and adverse effects associated with this shrub.2–6 NDGA shows promise in the treatment of multiple diseases, including cardiovascular diseases,7,8 neurological disorders9–13 and cancers.3,14–20 It also potently inhibits viruses such as human immunodeficiency virus (HIV-1), herpes simplex virus (HSV), human papilloma virus (HPV) and influenza virus.2,21

    • Pathoetiological Model of Delirium: a Comprehensive Understanding of the Neurobiology of Delirium and an Evidence-Based Approach to Prevention and Treatment

      2008, Critical Care Clinics
      Citation Excerpt :

      Hypoxic conditions may further extend GLU activity as the absence of extracellular mechanism of degradation require the functioning of ATP-dependent reuptake, which is impaired under these conditions [226]. GLU is an excitatory neurotransmitter that may lead to neuronal injury via its activation of NMDA receptors [267–271]. Nevertheless, it appears that GLU requires the presence of DA to exert some of its toxic effects, namely its Ca2+-induced neuronal injury [219,221,223,228].

    View all citing articles on Scopus
    View full text